Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.8.0.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2017
Dec. 31, 2016
Current assets:    
Cash and cash equivalents $ 100,362 $ 168,733
Accounts receivable, net 233,916 220,284
Inventory, net 46,954 47,228
Other current assets and prepaid expenses 49,324 47,356
Total current assets 430,556 483,601
Property, plant and equipment, net 142,437 122,831
Intangible assets, net 714,552 763,976
In-process research and development 648,377 644,713
Goodwill 715,573 704,603
Investments 32,196 41,139
Other assets 38,299 5,756
Total assets 2,721,990 2,766,619
Current liabilities:    
Accounts payable 66,536 53,360
Accrued expenses 176,300 197,955
Current portion of lines of credit and notes payable 16,112 11,981
Total current liabilities 258,948 263,296
2033 Senior Notes, net of discount 28,590 43,701
Deferred tax liabilities, net 118,799 165,331
Other long-term liabilities, principally deferred revenue, contingent consideration and line of credit 226,617 202,483
Total long-term liabilities 374,006 411,515
Total liabilities 632,954 674,811
Equity:    
Common Stock - $0.01 par value, 750,000,000 shares authorized; 559,955,118 and 558,576,051 shares issued at September 30, 2017 and December 31, 2016, respectively 5,600 5,586
Treasury Stock - 549,907 and 586,760 shares at September 30, 2017 and December 31, 2016, respectively (1,791) (1,911)
Additional paid-in capital 2,883,026 2,845,096
Accumulated other comprehensive loss (5,422) (27,009)
Accumulated deficit (792,377) (729,954)
Total shareholders’ equity 2,089,036 2,091,808
Total liabilities and equity $ 2,721,990 $ 2,766,619